Maven Securities’s Bristol-Myers Squibb BMY Stock Holding History

Maven Securities’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-4,600	Closed	-$294K	–	1080
2023 Q2	$294K	Sell	4,600 -3,100	-40%	-$208K	﹤0.01%	739
2023 Q1	$534K	Sell	7,700 -12,100	-61%	-$853K	0.01%	637
2022 Q4	$1.42M	Buy	+19,800	New	+$1.49M	0.03%	338
2022 Q3	–	Sell	-27,600	Closed	-$2.13M	–	1096
2022 Q2	$2.13M	Buy	27,600 +4,900	+22%	+$373K	0.06%	214
2022 Q1	$1.66M	Buy	+22,700	New	+$1.52M	0.06%	230
2021 Q4	–	Sell	-9,100	Closed	-$538K	–	854
2021 Q3	$538K	Sell	9,100 -5,100	-36%	-$336K	0.02%	637
2021 Q2	$949K	Buy	+14,200	New	+$926K	0.04%	465

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Maven Securities's BMY Position: Q1 2025 in Review

Maven Securities sold out of Bristol-Myers Squibb (BMY) in Q1 2025, closing a stake of 16,688 shares — an estimated $944K sold.

Maven Securities first reported a position in BMY in Q2 2021 and held it in 8 quarters. The position peaked at $1.83M in Q3 2022. 2,477 funds tracked by Wall St. Rank hold BMY as of Q1 2025.

Maven Securities reported no remaining Bristol-Myers Squibb position as of Q1 2025 after selling out during the quarter.
Maven Securities sold 16,688 Bristol-Myers Squibb shares in Q1 2025, an estimated $944K.
Maven Securities first reported a position in Bristol-Myers Squibb in Q2 2021 and held it in 8 quarters.
Maven Securities's Bristol-Myers Squibb position peaked at $1.83M in Q3 2022.
2,477 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2025.

Based on Maven Securities's 13F filing for Q1 2025, filed 14 May 2025.